Literature DB >> 22057420

Low prevalence of STEC autotransporter contributing to biofilm formation (Sab) in verocytotoxin-producing Escherichia coli isolates of humans and raw meats.

G Buvens1, D Piérard.   

Abstract

Escherichia coli autotransporters (AT) are known to confer adherence to eukaryotic extracellular matrix and may, therefore, be virulence-associated. Recently, the plasmid-borne STEC AT contributing to biofilm formation (Sab) was described in verocytotoxin (VT)-producing E. coli (VTEC) strains that do not carry the locus of enterocyte effacement (LEE). Using polymerase chain reaction (PCR), we investigated the prevalence of sab and other virulence genes, VT1 (vtx1), VT2 (vtx2), intimin (eae), enterohemolysin (ehxA), STEC autoagglutinating adhesin (saa), and subtilase cytotoxin (subA), in VTEC isolates from patients (n=263) and raw meats of ruminants and wildlife (n=104) in Belgium from 1990 to 2010. Overall, sab was detected in three (0.82%) of 367 VTEC strains comprising human isolates of serotypes O162:H28 (no clinical data available) and OX183:H18 (patient with abdominal pain), and one ground beef O181:H16 isolate. These three sab-positive isolates were eae-negative, but ehxA-, saa-, and subA-positive. Our data show that sab is uncommon in VTEC isolates. All sab-positive VTEC strains identified to date carried a comparable plasmid-bound virulence profile (ehxA-saa-subA-sab), which may be transmitted to other strains. Sab may mediate intestinal adherence in some LEE-negative VTEC isolates, but more studies on its prevalence and function are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057420     DOI: 10.1007/s10096-011-1464-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP.

Authors:  Adrienne W Paton; Travis Beddoe; Cheleste M Thorpe; James C Whisstock; Matthew C J Wilce; Jamie Rossjohn; Ursula M Talbot; James C Paton
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

Review 2.  Autotransporter proteins: novel targets at the bacterial cell surface.

Authors:  Timothy J Wells; Jai J Tree; Glen C Ulett; Mark A Schembri
Journal:  FEMS Microbiol Lett       Date:  2007-07-04       Impact factor: 2.742

3.  Prevalence of the operon encoding subtilase cytotoxin in non-O157 Shiga toxin-producing Escherichia coli isolated from humans in the United States.

Authors:  Jennifer J Wolfson; Dakshina M Jandhyala; Lynn A Gorczyca; Zulekha Qadeer; Shannon D Manning; James Hadler; James T Rudrik; Cheleste M Thorpe
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

4.  Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins.

Authors:  Claire Jenkins; Neil T Perry; Tom Cheasty; Darren J Shaw; Gad Frankel; Gordon Dougan; George J Gunn; Henry R Smith; Adrienne W Paton; James C Paton
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 6.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011.

Authors:  F Scheutz; E Møller Nielsen; J Frimodt-Møller; N Boisen; S Morabito; R Tozzoli; J P Nataro; A Caprioli
Journal:  Euro Surveill       Date:  2011-06-16

8.  Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.

Authors:  A W Paton; M C Woodrow; R M Doyle; J A Lanser; J C Paton
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 9.  Enterohaemorrhagic Escherichia coli in human medicine.

Authors:  Helge Karch; Phillip I Tarr; Martina Bielaszewska
Journal:  Int J Med Microbiol       Date:  2005-10       Impact factor: 3.473

10.  A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.

Authors:  Adrienne W Paton; Potjanee Srimanote; Ursula M Talbot; Hui Wang; James C Paton
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  1 in total

1.  Structural Elucidation of the O-Antigen Polysaccharide from Escherichia coli O181.

Authors:  Carolina Fontana; Andrej Weintraub; Göran Widmalm
Journal:  ChemistryOpen       Date:  2014-12-01       Impact factor: 2.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.